Key Takeaways Novel hormone-targeting perimenopause weight loss medication retatrutide Its triple-action mechanism, simultaneously stimulating GLP-1, GIP, and glucagon receptors, could potentially provide superior appetite control and metabolic advantages compared to conventional therapies
What does not adjust is guessing
The Short Answer How Semaglutide and Tirzepatide Work Differently Both medications mimic hormones your body naturally produces after eating, which signal your brain to reduce appetite, slow digestion, and regulate blood sugar
Can preservatives in compounded GLP-1 medications cause itching
Skipping dose steps raises the risk of nausea, vomiting, and dehydration
That makes retatrutide most valuable in designs asking integrated questions energy expenditure, hepatic lipid handling, multi-receptor signalling rather than mechanism-isolation questions, where a single-receptor tool is cleaner